Huxley Medical Expands SANSA Platform with New Diagnostic Features

June 11, 2026
Huxley Medical has added SANSA GO, a point of care enrollment model, and a new cardiovascular risk marker called hypoxic burden to its SANSA diagnostic platform. The updates expand the system's use for sleep apnea and cardiac monitoring.

Huxley Medical has expanded its SANSA diagnostic platform with two new additions: SANSA GO and a cardiovascular risk marker called hypoxic burden, announced in a press release.

SANSA GO is a point of care enrollment model that allows clinics to provide the SANSA device directly during patient visits. It complements the existing SANSA Express home enrollment option and is designed to match the operational flexibility of cardiac monitoring programs. The SANSA platform, cleared by the FDA, measures electrocardiograms, obstructive sleep apnea, and central sleep apnea using a single chest patch.

The new hypoxic burden feature adds a measure of cardiovascular strain linked to sleep apnea. In a study of 325 patients, those with cardiovascular disease and arrhythmias were more than twice as likely to show elevated hypoxic burden levels. Findings from the study will be presented at the SLEEP 2026 meeting in Baltimore.

Both SANSA GO and the hypoxic burden feature will be available nationwide during the SLEEP 2026 meeting, scheduled for June 14 to 17.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)

More from: Life Sciences

06/11
XtalPi Partners with Biopharma Company to Develop Oral Small Molecule Therapeutics
06/11
qBotica and Atolio Partner to Embed Secure AI Search in Automation Workflows
06/11
Sky Labs Highlights CART BP Pro at European Hypertension and Cardiology Conferences
06/10
XFERALL Launches AI Powered Patient Intake Suite for Behavioral Health Transfers
06/10
Aignostics and PanCAN Collaborate on AI Spatial Profiling for Pancreatic Cancer Research

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more

You May Also Like